2014
DOI: 10.1016/j.cmet.2014.09.003
|View full text |Cite
|
Sign up to set email alerts
|

Brain Insulin Lowers Circulating BCAA Levels by Inducing Hepatic BCAA Catabolism

Abstract: Summary Circulating branched-chain amino acid (BCAA) levels are elevated in obesity/diabetes and are a sensitive predictor for type 2 diabetes. Here we show in rats that insulin dose-dependently lowers plasma BCAA levels through induction of hepatic protein expression and activity of branched-chain α keto-acid dehydrogenase (BCKDH), the rate-limiting enzyme in the BCAA degradation pathway. Selective induction of hypothalamic insulin signaling in rats and genetic modulation of brain insulin receptors in mice de… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

14
140
2

Year Published

2015
2015
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 129 publications
(157 citation statements)
references
References 46 publications
14
140
2
Order By: Relevance
“…This finding suggests that, in mice, other tissues likely contribute to the changes in BCAA levels. A recent study describes the effects of insulin on hepatic protein levels and activity of BCKDH in controlling BCAA catabolism [30]. Since ob/ ob mice are hyperinsulinaemic, the plasma BCAA concentrations may be influenced more strongly by hepatic BCKDH in ob/ob mice, which is also supported by the strong correlations of plasma α-ketoisocaproic acid and hepatic BCAA in the correlation network of the ob/ob mice.…”
Section: Discussionmentioning
confidence: 92%
“…This finding suggests that, in mice, other tissues likely contribute to the changes in BCAA levels. A recent study describes the effects of insulin on hepatic protein levels and activity of BCKDH in controlling BCAA catabolism [30]. Since ob/ ob mice are hyperinsulinaemic, the plasma BCAA concentrations may be influenced more strongly by hepatic BCKDH in ob/ob mice, which is also supported by the strong correlations of plasma α-ketoisocaproic acid and hepatic BCAA in the correlation network of the ob/ob mice.…”
Section: Discussionmentioning
confidence: 92%
“…In contrast to the prevailing view that these mice might exhibit metabolic syndrome (62,63), they instead exhibited decreased adiposity and body weight and resistance to diet-induced obesity, even though they ate more food than their wild-type counterparts. In addition, BCATm KO mice exhibited 33% reductions in their plasma glucose levels, a ϳ50% reduction in glucose tolerance test (GTT) areas under the curve along with ϳ50% reductions in plasma insulin during the GTT and improved insulin sensitivity, but not maximal insulin action (76,79). However, these mice also had reduced exercise tolerance (76).…”
mentioning
confidence: 99%
“…[53][54][55][56] We have recently revealed for the first time the role of insulin in the regulation of BCAA metabolism by demonstrating that insulin dose-dependently lowers plasma BCAAs independent of glycemia via induction of hepatic BCAA catabolism. 51 We further showed that this control of BCAA metabolism is mediated primarily through insulin action in the brain, and that impaired BCAA metabolism and the resultant higher plasma BCAA levels ensue in a state of central insulin resistance.…”
mentioning
confidence: 76%
“…49 Rather, the increased circulating BCAAs and their intermediates may be because of decreased or impaired BCAAs degradation in tissues like liver, muscle, and adipose tissue. This concept of impaired BCAAs metabolism in obesity and diabetes is supported by findings demonstrating decreased gene expressions of BCAA-degrading enzymes in subcutaneous and omental fat tissues in obese twins compared to their lean monozygotic co-twins, 50 decreased protein or activity of branched-chain α-keto acid dehydrogenase (BCKDH), the rate-limiting enzyme in BCAA degradation pathway, in livers of obese ob/ob mice and diabetic fa/fa rats, 8 in HFD fed rats and diet-induced obese men and monkeys, 51 as well as in obese Pima Indians. 52 The reasons for dysregulated BCAA metabolism in obese and diabetics are unclear.…”
mentioning
confidence: 89%